siRNA, Anti-PKD2L1, LNA-modified(CAT#: SIRGT29730WQ-LNA)

The product SIRGT29730WQ-LNA is a type of small interfering RNA (siRNA) that targets PKD2L1 gene and regulates the expression of gene. The siRNA interferes with the expression of PKD2L1 gene with complementary nucleotide sequences by degrading mRNA after transcription, preventing translation. The siRNA is systematically modified with the synthetic RNA-like high affinity nucleotide analogue, Locked Nucleic Acid (LNA), to improve its bio-stability, specificity and efficiency. It has potential applications in RNA interference (RNAi) and gene therapy development.

Specifications
Modification Locked Nucleic Acid (LNA)
Scale 20/50/100/200 nmole
NCBI RefSeq NM_001253837.1; NM_016112.2
Alternative Names PCL; PKD2L; PKDL; TRPP3
Related Diseases Polycystic Kidney Disease
Purification HPLC
Target Gene
Gene ID 9033
Uniprot ID Q9P0L9

Related Products